Sandoz Simvastatin 20 mg

Simvastatin Sandoz is a generic pharmaceutical product designed to lower cholesterol and prevent cardiovascular disease. The brand, Sandoz, has a storied history dating back to 1886 in Basel, Switzerland, where it was founded as Kern & Sandoz. It eventually became half of one of the largest corporate mergers in history when it joined Ciba-Geigy to form Novartis in 1996.

While Sandoz was a pioneer in the development of various chemical and medicinal compounds, it spent decades as the generic pharmaceuticals division of the Novartis Group. However, in October 2023, Sandoz was officially spun off from Novartis to become an independent, publicly traded company. Today, Sandoz operates as a global leader in generic and biosimilar medicines, with its ultimate headquarters still located in Basel, Switzerland. Manufacturing is carried out across a global network of specialized pharmaceutical facilities, though the local distribution for the package shown is managed by Sandoz nv/sa in Belgium.